REGENEVE LTD
Significant control: Paul Simon Cooklin (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
What does Regeneve Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
REGENEVE LTD is an active private limited company (company number 17361640) incorporated on 25 July 2026, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). No accounts have been filed yet; the first accounts are due by 25 April 2028.
There are 603 companies in research and experimental development on biotechnology in London with filed accounts; the median reports net assets of £440 and is 6 years old.
Ownership and control
- Mr Paul Simon Cooklin
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 25 July 2026under 1 yr ago
- First accounts due
- 25 April 2028in 550 days
- Confirmation statement due
- 8 August 2027in 289 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- No Accounts Filed
Financials
No accounts filed yet. The first accounts are due by 25 April 2028; this page updates when they are filed.
Timeline
- First accounts duein 550 days
- Confirmation statement duein 289 days
- Incorporated
Similar companies in London
Reminders for REGENEVE LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.